Cravatex closes trading window from July 1 till Q1FY26 results
Cravatex Limited has closed its trading window for designated persons and their dependents effective July 1, 2026. The window will reopen 48 hours after the unaudited financial results for the quarter ended June 30, 2026 are declared. This move is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

*this image is generated using AI for illustrative purposes only.
Cravatex Limited has closed its trading window for designated persons and their dependents effective July 1, 2026, to prevent insider trading ahead of its quarterly financial announcement. The restriction will remain in force until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. This measure ensures compliance with regulatory norms regarding the trading of securities by insiders during sensitive periods.
The closure follows the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and the company's internal Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons. Under these regulations, designated persons are prohibited from dealing in the company's securities while the window is shut.
The trading window is a standard mechanism used by listed companies to restrict trading by insiders when they might possess unpublished price-sensitive information (UPSI). By keeping the window closed until 48 hours post-results declaration, Cravatex Limited aims to ensure that all material information is publicly available before any trading activity resumes.
The unaudited financial results for the quarter ended June 30, 2026, are expected to be announced shortly. Once the results are declared, the designated persons and their dependants will be permitted to resume trading in the company's securities after the mandatory 48-hour cooling-off period.
Historical Stock Returns for Cravatex
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.74% | +10.53% | +16.21% | +2.51% | -9.66% | +32.34% |
What are the market expectations for Cravatex Limited's Q2 2026 financial performance?
How might the trading window closure impact investor sentiment ahead of the results announcement?
Will the unaudited results reveal any significant shifts in Cravatex's revenue or profit margins compared to the previous quarter?
































